Phase I and Pharmacokinetic Trial of Paclitaxel (Taxol) Given as a 3-Hour Infusion in Pediatric Patients With Refractory Malignancy [clinicaltrials:NCT00001387]
Phase I and Pharmacokinetic Trial of Paclitaxel (Taxol) Given as a 3-Hour Infusion in Pediatric Patients With Refractory Malignancy [clinicaltrials:NCT00001387]
Bio2RDF identifier
NCT00001387
Bio2RDF namespace
clinicaltrials
Bio2RDF uri
http://bio2rdf.org/clinicaltrials:NCT00001387
identifiers.org URI
authority [clinicaltrials_vocabulary:authority]
brief summary [clinicaltrials_vocabulary:brief-summary]
The objective of this t ...... n with refractory malignancy.
brief title [clinicaltrials_vocabulary:brief-title]
Phase I and Pharmacokinetic Tr ...... nts With Refractory Malignancy
completion date [clinicaltrials_vocabulary:completion-date]
2000-07-01T00:00:00Z
condition [clinicaltrials_vocabulary:condition]
country [clinicaltrials_vocabulary:country]
detailed description [clinicaltrials_vocabulary:detailed-description]
Paclitaxel is an active ...... ers will be
determined.
download date [clinicaltrials_vocabulary:download-date]
ClinicalTrials.gov processed this data on August 10, 2015
eligibility [clinicaltrials_vocabulary:eligibility]
enrollment [clinicaltrials_vocabulary:enrollment]
firstreceived date [clinicaltrials_vocabulary:firstreceived-date]
1999-11-03T00:00:00Z
has expanded access [clinicaltrials_vocabulary:has-expanded-access]
intervention [clinicaltrials_vocabulary:intervention]
intervention browse [clinicaltrials_vocabulary:intervention-browse]
keyword [clinicaltrials_vocabulary:keyword]
Paclitaxel
Pharmacokinetics
lastchanged date [clinicaltrials_vocabulary:lastchanged-date]
2008-03-03T00:00:00Z
lead sponsor [clinicaltrials_vocabulary:lead-sponsor]
location [clinicaltrials_vocabulary:location]
nct id [clinicaltrials_vocabulary:nct-id]
NCT00001387
official title [clinicaltrials_vocabulary:official-title]
Phase I and Pharmacokinetic Tr ...... nts With Refractory Malignancy
org study id [clinicaltrials_vocabulary:org-study-id]
overall status [clinicaltrials_vocabulary:overall-status]
oversight [clinicaltrials_vocabulary:oversight]
phase [clinicaltrials_vocabulary:phase]
reference [clinicaltrials_vocabulary:reference]
secondary id [clinicaltrials_vocabulary:secondary-id]
source [clinicaltrials_vocabulary:source]
start date [clinicaltrials_vocabulary:start-date]
1994-09-01T00:00:00Z
study design [clinicaltrials_vocabulary:study-design]
study type [clinicaltrials_vocabulary:study-type]
url [clinicaltrials_vocabulary:url]
verification date [clinicaltrials_vocabulary:verification-date]
1999-08-01T00:00:00Z
identifier
clinicaltrials:NCT00001387
title
Phase I and Pharmacokinetic Tr ...... nts With Refractory Malignancy
@en
type
label
Phase I and Pharmacokinetic Tr ...... y [clinicaltrials:NCT00001387]
@en